# Mild behavioral impairment is longitudinally associated with frailty in very old adults with MCI: insights from COGFRAIL

**Authors:** Astrid Sawicki, Emmanuel Gonzalez-Bautista, Alberta Peluso, Gabor Abellan van Kan, Sandrine Sourdet, Maria Soto

PMC · DOI: 10.1007/s40520-025-03309-9 · 2026-02-03

## TL;DR

This study finds that mild behavioral issues in older adults with memory problems are linked to a faster decline in walking speed and a higher risk of becoming frail over time.

## Contribution

The study is the first to show a longitudinal link between specific MBI domains and frailty progression in older adults with mild cognitive impairment.

## Key findings

- Decreased motivation in older adults is associated with a steeper decline in gait speed over two years.
- Abnormal perception is also linked to faster gait speed decline.
- Higher severity of decreased motivation increases the risk of developing frailty.

## Abstract

The link between two often overlapping entities: mild behavioral impairment (MBI) and frailty has not been fully understood.

We aimed to investigate the longitudinal association between MBI and frailty.

Secondary analysis of COGFRAIL (clinicaltrials.gov NCT03129269). Real-life participants from the Toulouse Frailty Clinic with mild cognitive impairment were followed up for two years. MBI was measured using the NPI-Q. Frailty was defined by gait speed (GS) and Fried’s phenotype. We used mixed-effects models to analyse the longitudinal change in gait speed according to the presence and severity of MBI domains, and we examined the risk of incident frailty according to MBI status, using Cox models.

n = 234, mean age 83 SD ± 5.3, 58% (n = 135) were pre-frail at baseline. 12% were MBI-free. Participants with decreased motivation at baseline had a steeper decline in GS (p = 0.037), with higher severity directly associated with steeper decline (2-year mean decline of -0.047 m/s, 95% CI -0.092; -0.002). Similar results were found for the abnormal perception domain (2-year mean decline of -0.093 m/s, 95% CI: -0.155 to -0.032). Each higher severity points for decreased motivation at baseline resulted in a 33% higher risk of incident frailty than their counterparts over a mean follow-up of 284 days (SD 346), if measured at baseline HR = 1.33, (95% CI 1.07; 1.66), and as a time-varying variable HR = 1.39 (IC 95% 1.12; 1.72).

The MBI domains of decreased motivation and abnormal perception were longitudinally associated with a steeper decline in gait speed, and decreased motivation predicts incident frailty.

The online version contains supplementary material available at 10.1007/s40520-025-03309-9.

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** aggression (MESH:D010554), behavioral impairment (MESH:D001523), hypertension (MESH:D006973), delusions (MESH:D063726), dysphoria (MESH:D019052), cerebral amyloid (MESH:D016657), GS (MESH:D020234), neuropsychiatric (MESH:C000631768), Frailty (MESH:D000073496), indifference (MESH:D000699), aberrant motor behavior (MESH:D002869), hallucinations (MESH:D006212), cancer (MESH:D009369), disinhibition (MESH:D057180), white matter lesions (MESH:D056784), fatigue (MESH:D005221), Dementia (MESH:D003704), abnormal (MESH:D000014), affective dysregulation (MESH:D021081), chronic obstructive pulmonary disorder (MESH:D029424), weight loss (MESH:D015431), decreased motivation and abnormal perception (MESH:C535473), heart failure (MESH:D006333), cognitive and functional decline (MESH:D003072), agitation (MESH:D011595), diminished (MESH:D015354), Depression (MESH:D003866), decreased motivation (MESH:D009123), paranoid thoughts (MESH:D010259), speed (MESH:D008569), psychosis (MESH:D011618), impulse dyscontrol (MESH:D007174), diabetes (MESH:D003920), social inappropriateness (MESH:D007177), emotional/affective dysregulation (MESH:D019964), inflammation (MESH:D007249), MBI (MESH:D060825), anxiety (MESH:D001007), hypercholesterolemia (MESH:D006937), organic brain disease (MESH:D001927), chronic kidney disease (MESH:D051436), arthritis (MESH:D001168), neurocognitive disorders (MESH:D019965), vascular lesions (MESH:D014652), involuntary loss (MESH:D014202)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12872730/full.md

---
Source: https://tomesphere.com/paper/PMC12872730